{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T06:34:49Z","timestamp":1697870089673},"reference-count":20,"publisher":"Media Sphere Publishing Group","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. nevrol. psikhiatr. im. S.S. Korsakova"],"published-print":{"date-parts":[[2015]]},"DOI":"10.17116\/jnevro20151153149-53","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T16:00:16Z","timestamp":1460649616000},"page":"49","source":"Crossref","is-referenced-by-count":4,"title":["Lipid spectrum changes and ECG in patients with paranoid schizophrenia in the course of therapy with atypical antipsychotics"],"prefix":"10.17116","volume":"115","author":[{"given":"L. P.","family":"Smirnova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. A.","family":"Parshukova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu. N.","family":"Borodyuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. G.","family":"Kornetova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. D.","family":"Tkacheva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. A.","family":"Seregin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. G.","family":"Burdovitsina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. V.","family":"Semke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/jnevro20151153149-53-1","doi-asserted-by":"crossref","unstructured":"Tandon R., Keshavan M., Nasrallah H. Schizophrenia, \u00abJust the Facts\u00bb What we know in 2008. Schizophrenia Research 2008; 100: 1243\u20141252.","DOI":"10.1016\/j.schres.2008.01.022"},{"key":"key-10.17116\/jnevro20151153149-53-2","unstructured":"Mukhametshina Z.F. Sotsial'noe funktsionirovanie i kachestvo zhizni bol'nykh shizofreniei (kliniko-sotsial'nye i psikhologicheskie aspekty): Avtoref. dis. ... kand. med. nauk. M 2009."},{"key":"key-10.17116\/jnevro20151153149-53-3","unstructured":"Semke A.V., Vetlugina T.P., Ivanova S.A., Rakhmazova L.D., Kornetova E.G., Fedorenko O.Yu., Lobacheva O.A. Biologicheskie i kliniko-sotsial'nye mekhanizmy razvitiya endogennykh psikhicheskikh zabolevanii. Sibirskii vestnik psikhiatrii i narkologii 2011; 4: 19\u201423."},{"key":"key-10.17116\/jnevro20151153149-53-4","unstructured":"Aleshkina G.A. Primenenie atipichnykh neiroleptikov v lechenii bol'nykh paranoidnoi shizofreniei, stradayushchikh sakharnym diabetom tipa 2: Avtoref. dis. ... kand. med. nauk. M 2010."},{"key":"key-10.17116\/jnevro20151153149-53-5","unstructured":"Gorobets L.N. Endokrinologicheskie aspekty problemy perenosimosti neirolepticheskoi terapii u bol'nykh shizofreniei (vozrastnye i gendernye faktory). Psikhiatr i psikhofarmakoter 2012; 1: 41\u201447."},{"key":"key-10.17116\/jnevro20151153149-53-6","unstructured":"Semke A.V., Mal'tseva Yu.L. Somaticheskie rasstroistva pri shizo\u00adfrenii. Tomsk: Izd-vo \u00abIvan Fedorov\u00bb 2009."},{"key":"key-10.17116\/jnevro20151153149-53-7","unstructured":"Neznanov N.G., Martynikhin I.A., Sokolyan N.A. Chastota i kharakter metabolicheskikh narushenii u bol'nykh shizofreniei. Obozrenie psikhiatrii i meditsinskoi psikhologii im. Bekhtereva 2009; 2: 17\u201420."},{"key":"key-10.17116\/jnevro20151153149-53-8","unstructured":"Teoreticheskie i prakticheskie aspekty psikhoneiroendokrinologii. Pod red. prof. L.N. Gorobets. M 2012."},{"key":"key-10.17116\/jnevro20151153149-53-9","unstructured":"Martynikhin I.A. Metabolicheskii sindrom u bol'nykh shizofreniei: Avtoref. dis. ... kand. med. nauk. SPb 2009."},{"key":"key-10.17116\/jnevro20151153149-53-10","unstructured":"Ozorin A.S., Ozorina N.V., Govorin N.V. Nekotorye patofiziologicheskie mekhanizmy izmeneniya lipidnogo spektra krovi pri antipsikhoticheskoi terapii u bol'nykh ostroi shizofreniei. Sotsial'naya i klinicheskaya psikhiatriya 2013; 23: 2: 45\u201449."},{"key":"key-10.17116\/jnevro20151153149-53-11","doi-asserted-by":"crossref","unstructured":"Roerig J.L., Steffen K.J., Mitchell J.E. Atypical antipsychotic-induced weight gain. Insights into Mechanisms of Action. Review J CNS Drugs 2011; 25: 12: 1035\u20141059.","DOI":"10.2165\/11596300-000000000-00000"},{"key":"key-10.17116\/jnevro20151153149-53-12","doi-asserted-by":"crossref","unstructured":"Melkersson K.I., Hulting A.L., Brismar K.E. Elevated levelsof nsulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses. J Clin Psychiatry 2000; 61: 742\u2014749.","DOI":"10.4088\/JCP.v61n1006"},{"key":"key-10.17116\/jnevro20151153149-53-13","unstructured":"Shchigoreva Yu.G., Smirnova L.P., Ivanova S.A., Fattakhov N.S., Gonchikova I.A., Popova T.A., Burdovitsina T.G., Semke A.V. Dinamika biokhimicheskikh pokazatelei belkovogo i uglevodnogo obmena v syvorotke krovi bol'nykh shizofreniei v protsesse farmakoterapii atipichnymi antipsikhotikami. Sibirskii vestnik psikhiatrii i narkologii 2013; 3: 78: 65\u201468."},{"key":"key-10.17116\/jnevro20151153149-53-14","unstructured":"Boiko A.S., Fedorenko O.Yu., Serebrov V.Yu., Semke A.V., Ivanova S.A. Kortizol i antitela k DNK u bol'nykh shizofreniei na fone anti\u00adpsikhoticheskoi terapii. Uspekhi sovremennogo estestvoznaniya 2013; 9: 22\u201424."},{"key":"key-10.17116\/jnevro20151153149-53-15","doi-asserted-by":"crossref","unstructured":"Chao Deng, Katrina Weston-Green, Xu-Feng Huang. The role of histaminergic H1 and H3 receptors in food intake: A mechanism for atypical antipsychotic-induced weight gain? Progress in Neuro-Psychopharmacology and Biological Psychiatry 2010; 1\u20144.","DOI":"10.1016\/j.pnpbp.2009.11.009"},{"key":"key-10.17116\/jnevro20151153149-53-16","unstructured":"Spravochnik Vidal'. Lekarstvennye preparaty v Rossii: spravochnik Rossiya. Izd-vo SpetsLit 2013; 1640."},{"key":"key-10.17116\/jnevro20151153149-53-17","unstructured":"D\u00e1vila I., Sastre J., Bartra J. et al. Effect of H1 antihistamines upon the cardiovascular system. J InvestigAllergol Clin Immunol 2006; 16: Suppl 1: 13\u201423."},{"key":"key-10.17116\/jnevro20151153149-53-18","unstructured":"Drogovoz S.M., Luk'yanchuk V.D., Sheiman B.S., Kononenko A.V. Toksicheskie effekty blokatorov H1-gistaminovykh retseptorov i mekhanizmy ikh formirovaniya. Sovremennye problemy toksikologii 2012; 3\u20144: 58\u201459."},{"key":"key-10.17116\/jnevro20151153149-53-19","doi-asserted-by":"crossref","unstructured":"Hedley P.L., Jorgensen P., Schlamowitz S. et al. The genetic basis of long QT and short QT syndromes: a mutation update. Human Mutation 2009; 30: 11: 1486\u20141511.","DOI":"10.1002\/humu.21106"},{"key":"key-10.17116\/jnevro20151153149-53-20","doi-asserted-by":"crossref","unstructured":"Nachimuthu S., Assar M.D., Schussler J.M. Drug-induced QT interval prolongation: mechanisms and clinical management. Ther Adv Drug Saf 2012; 3: 5: 241\u2014253.","DOI":"10.1177\/2042098612454283"}],"container-title":["Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T10:59:36Z","timestamp":1498301976000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova\/2015\/3\/downloads\/ru\/541997-72982015039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"alternative-id":["jnevro20151153149-53"],"URL":"https:\/\/doi.org\/10.17116\/jnevro20151153149-53","relation":{},"ISSN":["1997-7298"],"issn-type":[{"value":"1997-7298","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}